1-6 of 6
Eric C. Holland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma

Available to Purchase
Peter B. Dirks, Mark R. Gilbert, Eric C. Holland, Elizabeth A. Maher, William A. Weiss
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2457–2460.
https://doi.org/10.1158/1078-0432.CCR-19-3924
Published: 01 June 2020
View articletitled, Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma
Open the PDF for Translating Basic Science Discoveries into Improved Outcomes for Glioblastoma in another window
Journal Articles

Magnetic Resonance Imaging Determination of Tumor Grade and Early Response to Temozolomide in a Genetically Engineered Mouse Model of Glioma

Available to Purchase
Patrick McConville, Dolores Hambardzumyan, Jonathan B. Moody, Wilbur R. Leopold, Alicia R. Kreger, Michael J. Woolliscroft, Alnawaz Rehemtulla, Brian D. Ross, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 2897–2904.
https://doi.org/10.1158/1078-0432.CCR-06-3058
Published: 15 May 2007
View articletitled, Magnetic Resonance Imaging Determination of Tumor Grade and Early Response to Temozolomide in a Genetically Engineered Mouse Model of Glioma
Open the PDF for Magnetic Resonance Imaging Determination of Tumor Grade and Early Response to Temozolomide in a Genetically Engineered Mouse Model of Glioma in another window
Journal Articles

YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas

Available to Purchase
Adília Hormigo, Bin Gu, Sasan Karimi, Elyn Riedel, Katherine S. Panageas, Mark A. Edgar, Meena K. Tanwar, Jasti S. Rao, Martin Fleisher, Lisa M. DeAngelis, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5698–5704.
https://doi.org/10.1158/1078-0432.CCR-06-0181
Published: 04 October 2006
View articletitled, YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas
Open the PDF for YKL-40 and Matrix Metalloproteinase-9 as Potential Serum Biomarkers for Patients with High-Grade Gliomas in another window
Journal Articles

Mouse Models of Brain Tumors and Their Applications in Preclinical Trials

Available to Purchase
Elena I. Fomchenko, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5288–5297.
https://doi.org/10.1158/1078-0432.CCR-06-0438
Published: 25 September 2006
View articletitled, Mouse Models of Brain Tumors and Their Applications in Preclinical Trials
Open the PDF for Mouse Models of Brain Tumors and Their Applications in Preclinical Trials in another window
Journal Articles

Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01

Available to Purchase
Andrew B. Lassman, Michael R. Rossi, Jeffrey R. Razier, Lauren E. Abrey, Frank S. Lieberman, Chelsea N. Grefe, Kathleen Lamborn, William Pao, Alan H. Shih, John G. Kuhn, Richard Wilson, Norma J. Nowak, John K. Cowell, Lisa M. DeAngelis, Patrick Wen, Mark R. Gilbert, Susan Chang, W.A. Yung, Michael Prados, Eric C. Holland
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7841–7850.
https://doi.org/10.1158/1078-0432.CCR-05-0421
Published: 08 November 2005
View articletitled, Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
Open the PDF for Molecular Study of Malignant Gliomas Treated with Epidermal Growth Factor Receptor Inhibitors: Tissue Analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01 in another window
Includes: Supplementary data
Journal Articles

Allelic Losses at 1p36 and 19q13 in Gliomas: Correlation with Histologic Classification, Definition of a 150-kb Minimal Deleted Region on 1p36, and Evaluation of CAMTA1 as a Candidate Tumor Suppressor Gene

Available to Purchase
Violetta Barbashina, Paulo Salazar, Eric C. Holland, Marc K. Rosenblum, Marc Ladanyi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1119–1128.
https://doi.org/10.1158/1078-0432.1119.11.3
Published: 11 February 2005
View articletitled, Allelic Losses at 1p36 and 19q13 in Gliomas: Correlation with Histologic Classification, Definition of a 150-kb Minimal Deleted Region on 1p36, and Evaluation of CAMTA1 as a Candidate Tumor Suppressor Gene
Open the PDF for Allelic Losses at 1p36 and 19q13 in Gliomas: Correlation with Histologic Classification, Definition of a 150-kb Minimal Deleted Region on 1p36, and Evaluation of CAMTA1 as a Candidate Tumor Suppressor Gene in another window